Bone marrow specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis

Although the pathogenesis of primary myelofibrosis (PMF) and other myeloproliferative neoplasms (MPNs) is linked to constitutive activation of the JAK-STAT pathway, JAK inhibitors have neither curative nor MPN-stem cell-eradicating potential, indicating that other targetable mechanisms are contributing to the pathophysiology of MPNs. We previously demonstrated that Abelson interactor 1 (Abi-1), a negative regulator of Abelson kinase 1, functions as a tumor suppressor. Here we present data showing that bone marrow-specific deletion of Abil in a novel mouse model leads to development of an MPN-like phenotype resembling human PMF. Abi-1 loss resulted in a significant increase in the activity of the Src family kinases (SFKs), STAT3, and NF-kappa B signaling. We also observed impairment of hematopoietic stem cell self-renewal and fitness, as evidenced in noncompetitive and competitive bone marrow transplant experiments. CD34(+) hematopoietic progenitors and granulocytes from patients with PMF showed decreased levels of ABIl transcript as well as increased activity of SFKs, STAT3, and NF-kappa B. In aggregate, our data link the loss of Abi-1 function to hyperactive SFKs/ST/NF-kappa B signaling and suggest that this signaling axis may represent a regulatory module involved in the molecular pathophysiology of PMF.